Clinical Trials Logo

Clinical Trial Summary

Accumulating evidence indicates that patient- derived organoids (PDOs) can predict drug responses in the clinic. Metastasis is the main cause of death in colorectal cancer patients, and the treatment of patients with liver metastasis remains poor. Tumor heterogeneity is the cause of treatment failure. In this study, we aim the investigate the consistency of drug sensitivity for the matched primary and metastatic tumor in patients with liver metastasis.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05183425
Study type Observational
Source Changhai Hospital
Status Not yet recruiting
Start date January 1, 2022
Completion date December 31, 2024